[Elsevier] Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy (ORIENT-31)

bryanphandhy Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-31 07:09
Reward50points

journalㄩThe Lancet Oncology


AuthorsㄩShun Lu; Lin Wu; Hong Jian; Ying Cheng; Qisen Guo; Jie Wang


Published dateㄩ2022-09-


DOIㄩ10.1016/S1470-2045(22)00382-5


PDF linkㄩhttps://www.sciencedirect.com/sc ... 470204522003825/pdf


Article linkㄩhttps://doi.org/10.1016/S1470-2045(22)00382-5


Article SourceㄩElsevier BV﹝


Remarkㄩ
Reply

Use magic Donate Report

All Reply1 Show all posts
NVP9 Post time Half hour(s) ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    1055


Daily Top Contributors

Return to the list